Michael Barbella, Managing Editor09.20.22
VitalConnect Inc. has welcomed a new executive team member.
The company recently appointed Amy Covert as chief financial officer (CFO). Covert brings more than 20 years of experience to the role, in both public and private companies, primarily within healthcare. She joins VitalConnect from HoverTech International, a medical device company, where she has served as CFO since 2019. At HoverTech, Covert had responsibility for finance and accounting as well as the operational organization which included manufacturing, sourcing, customer service and logistics. Prior to HoverTech, she held various financial leadership roles at BioTelemetry Inc., a remote cardiac monitoring company.
Covert earned her MBA and a Certificate in Accountancy from Villanova University. She graduated with a bachelor of science degree in finance and international business from The Pennsylvania State University.
“Amy brings a wealth of experience in building high-performance finance teams and driving organizational change to VitalConnect,” said Peter Van Haur, CEO of VitalConnect. “Over the past few years, we’ve attracted tremendous talent to the leadership team with the common goal of improving outcomes for physicians and patients. Adding a strong financial leader with Amy’s experience will allow VitalConnect to accelerate our already rapid growth in cardiac monitoring and remote patient management.”
Founded in 2011, VitalConnect has deployed more than 200,000 patches throughout the world, including care facilities such as Brigham and Women’s, Hackensack Medical Center, Northwell Health, and John Radcliffe Hospital-Oxford University. The VitalPatch allows real-time remote or in-hospital monitoring, allowing physicians to optimize the delivery of care to their patients. VitalConnect develops wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. The company's products are designed for use in a broad range of inpatient and outpatient settings, such as hospital monitoring, post-discharge care, cardiac monitoring and pharmaceutical solutions.
The company recently appointed Amy Covert as chief financial officer (CFO). Covert brings more than 20 years of experience to the role, in both public and private companies, primarily within healthcare. She joins VitalConnect from HoverTech International, a medical device company, where she has served as CFO since 2019. At HoverTech, Covert had responsibility for finance and accounting as well as the operational organization which included manufacturing, sourcing, customer service and logistics. Prior to HoverTech, she held various financial leadership roles at BioTelemetry Inc., a remote cardiac monitoring company.
Covert earned her MBA and a Certificate in Accountancy from Villanova University. She graduated with a bachelor of science degree in finance and international business from The Pennsylvania State University.
“Amy brings a wealth of experience in building high-performance finance teams and driving organizational change to VitalConnect,” said Peter Van Haur, CEO of VitalConnect. “Over the past few years, we’ve attracted tremendous talent to the leadership team with the common goal of improving outcomes for physicians and patients. Adding a strong financial leader with Amy’s experience will allow VitalConnect to accelerate our already rapid growth in cardiac monitoring and remote patient management.”
Founded in 2011, VitalConnect has deployed more than 200,000 patches throughout the world, including care facilities such as Brigham and Women’s, Hackensack Medical Center, Northwell Health, and John Radcliffe Hospital-Oxford University. The VitalPatch allows real-time remote or in-hospital monitoring, allowing physicians to optimize the delivery of care to their patients. VitalConnect develops wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. The company's products are designed for use in a broad range of inpatient and outpatient settings, such as hospital monitoring, post-discharge care, cardiac monitoring and pharmaceutical solutions.